Related Experiment Video
Updated: May 27, 2026
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas
Pilar López-Nieva1, Concepción Vaquero, Pablo Fernández-Navarro
1Departmento Biología Celular e Inmunología, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Nicolás Cabrera 1, 28049 Madrid, Spain.
Abstract:
Cryptic deletions at chromosome 6q are common cytogenetic abnormalities in T-cell lymphoblastic leukemia/lymphoma (T-LBL), but the target genes have not been formally identified. Our results build on detection of specific chromosomal losses in a mouse model of γ-radiation-induced T-LBLs and provide interesting clues for new putative susceptibility genes in a region orthologous to human 6q15-6q16.3. Among these, Epha7 emerges as a bona fide candidate tumor suppressor gene because it is inactivated in practically all the T-LBLs analyzed (100% in mouse and 95.23% in human). We provide evidence showing that Epha7 downregulation may occur, at least in part, by loss of heterozygosity (19.35% in mouse and 12.5% in human) or promoter hypermethylation (51.61% in mouse and 43.75% in human) or a combination of both mechanisms (12.90% in mouse and 6.25% in human). These results indicate that EPHA7 might be considered a new tumor suppressor gene for 6q deletions in T-LBLs. Notably, this gene is located in 6q16.1 proximal to GRIK2 and CASP8AP2, other candidate genes identified in this region. Thus, del6q seems to be a complex region where inactivation of multiple genes may cooperatively contribute to the onset of T-cell lymphomas.
Insights
Chromosomal deletions in T-cell lymphoblastic leukemia/lymphoma (T-LBL) implicate Epha7 as a tumor suppressor. Inactivation of Epha7, through loss of heterozygosity or promoter hypermethylation, contributes to T-LBL development.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Chromosome 6q deletions are frequent in T-cell lymphoblastic leukemia/lymphoma (T-LBL).
- The specific genes targeted by these deletions remain largely unidentified.
- Understanding these genetic alterations is crucial for T-LBL pathogenesis research.
Purpose of the Study:
- To identify novel susceptibility genes within the 6q15-6q16.3 region implicated in T-LBL.
- To investigate the role of the Epha7 gene as a potential tumor suppressor in T-LBL.
- To elucidate the mechanisms of Epha7 inactivation in T-cell lymphomas.
Main Methods:
- Analysis of chromosomal losses in a mouse model of gamma-radiation-induced T-LBL.
- Detection of Epha7 inactivation in both mouse and human T-LBL samples.
- Assessment of loss of heterozygosity and promoter hypermethylation as mechanisms for Epha7 downregulation.
Main Results:
- Epha7 was found to be inactivated in a high percentage of T-LBLs (100% in mouse, 95.23% in human).
- Mechanisms of inactivation included loss of heterozygosity (19.35% mouse, 12.5% human) and promoter hypermethylation (51.61% mouse, 43.75% human).
- Epha7 is located in 6q16.1, near other candidate T-LBL genes like GRIK2 and CASP8AP2.
Conclusions:
- EPHA7 is identified as a novel tumor suppressor gene associated with 6q deletions in T-LBL.
- The inactivation of EPHA7 contributes to the development of T-cell lymphomas.
- The 6q deletion region likely involves multiple genes cooperating in lymphomagenesis.
Related Concept Videos
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase